IHM
INSM icon

Iguana Healthcare Management’s Insmed INSM Stock Holding History

Iguana Healthcare Management’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-50,000
Closed -$1.56M – 70
2017
Q3 		$1.56M Buy
+50,000
New +$952K 0.85% 42

Other funds holding INSM

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Iguana Healthcare Management's INSM Position: Q4 2017 in Review

Iguana Healthcare Management sold out of Insmed (INSM) in Q4 2017, closing a stake of 50,000 shares — an estimated $1.56M sold.

Iguana Healthcare Management first reported a position in INSM in Q3 2017 and held it in 1 quarter. The position peaked at $1.56M in Q3 2017. 129 funds tracked by Wall St. Rank hold INSM as of Q4 2017.

  • Iguana Healthcare Management reported no remaining Insmed position as of Q4 2017 after selling out during the quarter.
  • Iguana Healthcare Management sold 50,000 Insmed shares in Q4 2017, an estimated $1.56M.
  • Iguana Healthcare Management first reported a position in Insmed in Q3 2017 and held it in 1 quarter.
  • Iguana Healthcare Management's Insmed position peaked at $1.56M in Q3 2017.
  • 129 funds tracked by Wall St. Rank held Insmed as of Q4 2017.

Based on Iguana Healthcare Management's 13F filing for Q4 2017, filed 14 Feb 2018.